Marketfy Has Evolved - We're Moving to a New Platform!

Today, we're thrilled to share some exciting news about the future of our cannabis research platform (formerly on Marketfy). As part of our ongoing commitment to provide you with the most comprehensive insights and valuable research in the cannabis market, we are making a strategic transition that will enhance our offerings and the way we serve you.

We Are Moving!

Our service is migrating from Marketfy to a new home within our Benzinga Research Portal.

Enter Benzinga Cannabis Research. This move is more than just a change of address: it's a significant leap forward in our mission to deliver unparalleled market research. By integrating with Benzinga's advanced research platform, we will unlock new capabilities and resources to empower your investment decisions, guided by the expert insights of our analyst Michael Berger.

How To Log In

You can use the same email and password you used to log into Marketfy to log into Benzinga Research. Should you have any questions, please email newsletters@benzinga.com

What This Means for You

  • Enhanced Platform & Increased Functionality: The transition to Benzinga Research offers a more robust platform with enhanced functionality. You'll experience a seamless shift with no interruptions to your service – just a new and improved interface where we'll continue to offer the insightful content you've come to expect.

  • A Focused Strategy on Swing Trades: Benzinga is the go-to platform for Swing trades, with a timeframe ranging from 1 week to 1 year. This adjustment will better define our market niche and align our offerings with your investment goals.
  • Trade Alerts - Instant Updates: Get real-time trade alerts and market commentary with the Benzinga app. Download, log in, and enable push notifications to stay ahead. Don’t miss Michael’s Important Messages for exclusive insights.
  • Subscription Model Update: To ensure we provide the ...
Read More
Comments

420 Investor Weekly Review 12/23/22

Review

Canada reported October cannabis sales of C$389 million, up 9.5% from a year ago and the slowest annual growth to date.

I distributed this written material to 420 Investor subscribers during the week:

Read More
Comments

420 Investor Weekly Review 12/16/22

Review

Illinois released its medical cannabis sales for November. The state saw total cannabis sales fall 0.8% from October but rise 4.2% from a year ago to $158.7 million. Michigan released its November cannabis sales, with the total gaining 33.2% ...

Read More
Comments

420 Investor Weekly Review 12/09/22

Review

The SAFE Banking measure was removed from inclusion in the National Defense Authorization Act. Connecticut announced the opening date for retail cannabis sales as January 10th.

I distributed this written material to 420 Investor subscribers during the week:

Read More
Comments

420 Investor Weekly Review 12/02/22

Review

President Biden signed the CBD research bill into law.

I distributed this written material to 420 Investor subscribers during the week:

Read More
Comments

420 Investor Weekly Review 11/25/22

Review

The FDA warned five companies that are illegally selling food and beverage products with CBD. New York issued 36 adult-use retail licenses and will delay the current 10 medical operators from opening adult-use stores. Canadian sales of cannabis were ...

Read More
Comments

420 Investor Weekly Review 11/18/22

Review

Michigan cannabis sales in October slipped sequentially by 1.2% but expanded by 28.1% from a year ago to $209.4 million.

I distributed this written material to 420 Investor subscribers during the week:

Read More
Comments

420 Investor Weekly Review 11/11/22

Review

Two of the five states voting to legalize cannabis for adult-use, Maryland and Missouri, passed it, while three others, Arkansas, North Dakota and South Dakota, voted against doing so.

I distributed this written material to 420 Investor subscribers during ...

Read More
Comments

420 Investor Weekly Review 11/04/22

Review

Illinois released both adult-use and medical cannabis data for October, with sales of $160 million, up 0.8% sequentially and 3.1% from a year ago. BDSA data for September suggested that sales remained weak in most markets.

I distributed this ...

Read More
Comments

420 Investor Weekly Review 10/28/22

Review

The big news for the industry this week was the announcement by Canopy Growth regarding its U.S. acquisitions, which opens the door potentially for MSOs to trade on the NASDAQ. Also, Germany appears to be moving forward with its ...

Read More
Comments

420 Investor Weekly Review 10/21/22

Review

Canadian cannabis sales in August rose 0.2% to C$393.7 million. This was up only 13% from a year ago, the slowest annual growth yet. A German plan to legalize for adult-use was leaked.

I distributed this written material to ...

Read More
Comments

420 Investor Weekly Review 10/14/22

Review

Michigan cannabis sales expanded 2% sequentially in September to a record $212 million, up 31.4% from a year ago. Illinois added medical data for September to the previously released adult-use data, and that state saw sales rise 0.2% sequentially ...

Read More
Comments